Filing Flows

Filing Flows › Consumer Staples › Petmed Express (PETS)

Petmed Express (PETS) earnings and revenue breakdown

Latest: Q1 FY27 · 10-Q filed Aug 13, 2026 · Petmed Express (PETS) Q1 FY27 earnings results →

Q1 FY27 Revenue down 20% year over year to $41.0M · 15¢ of every $1 of revenue lost · operating margin -15.2%

Petmed Express made $41.0M in Q1 FY27 (-20% Y/Y). Operating margin -15.2%, net loss $6.1M. See where every dollar goes — costs, profit and cash — as a Sankey from the 10-Q filed Aug 13, 2026.

Revenue$41.0M
Year over year-20%
Operating margin-15.2%
Net earnings−$6.1M
Operating cash flow−$7.7M

Drawing the Sankey…

Open the interactive Sankey → click any line for what the company wrote about it, compare Y/Y and Q/Q, export as PNG or PDF

What changed this quarter

Revenue was $41.0M in Q1 FY27, down 20% year over year and down 4% from the previous quarter.

Gross margin was 27.6%, down 0.5 points from Q1 FY26. Operating costs exceeded revenue by $6.2M, an operating margin of -15.2%. Operating expenses fell 64% while revenue fell 20%. The quarter ended with a net loss of $6.1M, wider than the previous quarter's $4.1M loss.

Operating cash flow was −$7.7M. Non-cash charges added back $2.1M of depreciation and amortization and $198K of share-based compensation. Working capital and other items used $3.9M. Capital expenditures of $641K exceeded it, leaving free cash flow of −$8.3M.

Quarterly history

Petmed Express revenue by quarterPetmed Express revenue by quarter$52.0MQ3 FY25$50.8MQ4 FY25$51.2MQ1 FY26$44.4MQ2 FY26$40.7MQ3 FY26$42.8MQ4 FY26$41.0MQ1 FY27
Petmed Express net earnings by quarterPetmed Express net earnings by quarter−$707KQ3 FY25−$11.6MQ4 FY25−$34.2MQ1 FY26−$8.5MQ2 FY26−$10.6MQ3 FY26−$4.1MQ4 FY26−$6.1MQ1 FY27
QuarterFormFiledRevenueY/YOp. marginNet earningsOp. cash flow
Q1 FY2710-QAug 13, 2026$41.0M-20%-15.2%−$6.1M−$7.7M
Q4 FY2610-KJun 2, 2026$42.8M-16%-13.3%−$4.1M−$4.7M
Q3 FY2610-QFeb 5, 2026$40.7M-22%-25.7%−$10.6M−$9.2M
Q2 FY2610-QDec 19, 2025$44.4M-24%-18.9%−$8.5M−$2.2M
Q1 FY2610-QDec 19, 2025$51.2M-23%-66.7%−$34.2M−$12.3M
Q4 FY2510-KOct 14, 2025$50.8M-24%-11.9%−$11.6M$7.0M
Q3 FY2510-QFeb 10, 2025$52.0M-20%-0.9%−$707K−$1.2M

Charts

Petmed Express: revenue growth, year over year and quarter over quarterPetmed Express: revenue growth, year over year and quarter over quarterY/YQ/Q-20%Q3 FY25-24%-2%Q4 FY25-23%+1%Q1 FY26-24%-13%Q2 FY26-22%-8%Q3 FY26-16%+5%Q4 FY26-20%-4%Q1 FY27
Latest (Q1 FY27): Y/Y -20%, Q/Q -4%.
Petmed Express: where the cash came from (+) and went (−), TTM to Q1 FY27Petmed Express: where the cash came from (+) and went (−), TTM to Q1 FY27Cash drawn (+) / kept (−)$28.0MOperating cash flow−$23.8MCapital spending−$4.0MTaxes on employees’ shares−$254KDividends−$20K
From the cash-flow statement as filed (SEC XBRL). Cash is fungible: the bars do not say which dollar paid for what.
Petmed Express: profit against cash, quarter by quarterPetmed Express: profit against cash, quarter by quarterNet incomeOperating cash flow$2.3M$7.4MQ2 FY25−$707K−$1.2MQ3 FY25−$11.6M$7.0MQ4 FY25−$34.2M−$12.3MQ1 FY26−$8.5M−$2.2MQ2 FY26−$10.6M−$9.2MQ3 FY26−$4.1M−$4.7MQ4 FY26−$6.1M−$7.7MQ1 FY27
Latest (Q1 FY27): Net income −$6.1M, Operating cash flow −$7.7M.
Petmed Express: diluted shares by fiscal yearPetmed Express: diluted shares by fiscal year20MFY2120MFY2220MFY2320MFY2421MFY2521MFY26
+4.0% since FY21: more shares outstanding (issuance, stock pay).

Interactive views

The same charts as the app — open one to draw it.

💵Where each $1 goesinteractive

Loading the interactive chart…

🌏Named in Asian annual reportsinteractive

Loading the interactive chart…

🔄Rotation against the market and its industry (RRG)interactive

Loading the interactive chart…

🔍Earnings qualityinteractive

Loading the interactive chart…

⚖️Fair value by methodinteractive

Loading the interactive chart…

🔭Outlook & guidanceinteractive

Loading the interactive chart…

📈Investments: gains and what it boughtinteractive

Loading the interactive chart…

🏭Its industry’s money flow (input-output)interactive

Loading the interactive chart…

About Petmed Express

PetMed Express, Inc. and subsidiaries, d/b/a PetMeds®, and as parent company of PetCareRx®, is a pioneer in pet healthcare, building a consumer-first digital platform in 1996 that transformed the way customers fulfill pet medications. Thirty years later, as a leading nationwide direct-to-consumer pet health and wellness retailer, the Company markets and sells directly to consumers through its websites (Petmeds.com and PetCareRx.com), customer contact centers, and mobile applications (iOS and Android). The Company provides access to top branded pharmaceuticals, generic medications, compounded prescription medications, over-the-counter (OTC) health and wellness products, prescription and non-prescription food, pharmacy fulfillment, and personalized AutoShip capabilities.

In its own words, from its 10-K, filed Jun 2, 2026.

Petmed Express against its Retail-Drug Stores and Proprietary Stores peers

The largest companies of the same SEC industry, each at its latest quarter. Revenue growth: -20% against the peers' median -2%. Operating margin: -15.2% against the peers' median 3.3%.

CompanyQuarterRevenueY/YOp. margin
PETS Petmed ExpressQ1 FY27$41.0M-20%-15.2%
CVS CVS HealthQ3 2026$108.4B+5%3.3%
GRDN Guardian Pharmacy ServicesQ3 2026$371M-2%6.8%

Source: Petmed Express 10-Q on SEC EDGAR · CIK 1040130 · Retail-Drug Stores and Proprietary Stores

13F: who owns PETS and who is buying

Largest holders of PETS (13F)Largest holders of PETS (13F)Vanguard Group$3.1MRenaissance Technologies LLC$2.2MVanguard Capital Management LLC$1.6MBlackRock$1.1MFederated Hermes$407KGeode Capital Management, LLC$392KSteel Partners Holdings L.P.$372KHtlf Bank$289KUBS Group AG$266KPrice T Rowe Associates$250K
Funds' net buying of PETS by quarter (13F)Funds' net buying of PETS by quarter (13F)−$2.0M2024-09−$291K2024-12−$4.4M2025-03−$1.3M2025-06−$1.2M2025-09−$4K2025-12−$2.3M2026-03−$2.6M2026-06
Value of shares 13F filers added minus the value they sold, each quarter (quarters with most filings in).

More on PETS

History

Every quarter: Q1 FY27 results · Q4 FY26 results · Q3 FY26 results · Q2 FY26 results · Q1 FY26 results · Q4 FY25 results · Q3 FY25 results

Compare PETS with

中文版:Petmed Express(PETS)财报

Español · Français